Moleculin
Business Services · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5300 Memorial Dr Ste 950, Houston, Texas...Phone Number
(713) 300-5160Website
www.moleculin.comRevenue
-Stock Symbol
MBRXIndustry
About Moleculin
Moleculin Biotech is a late-stage clinical pharmaceutical company developing Annamycin (naxtarubicin), a "next-generation" anthracycline, in a pivotal Phase 2/3 MIRACLE trial combined with cytarabine for relapsed/refractory acute myeloid leukemia. Technologies originate from licenses with UT MD Anderson Cancer Center. Interim June 2026 data showed higher remission rates versus control, though not yet statistically significant; final analysis pending across ~282 planned subjects.Explore more
SIC Code 28,283NAICS Code 54,541Ticker NASDAQ: MBRXShow moreMoleculin Org Chart
Compare Similar Companies to Moleculin
Compare insights from companies similar to Moleculin, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Moleculin Tech Stack
A closer look at the technologies used by Moleculin
See more technologies
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Moleculin
Sign Up For FreeTo access detailed company insights
Moleculin Biotech is a late-stage clinical pharmaceutical company developing Annamycin (naxtarubicin), a "next-generation" anthracycline, in a pivotal Phase 2/3 MIRACLE trial combined with cytarabine for relapsed/refractory acute myeloid leukemia. Technologies originate from licenses with UT MD Anderson Cancer Center. Interim June 2026 data showed... Read More

